GLP-1 Drugs Support-But Do Not Replace-Lifestyle Change, report patients in JAMA study Dr Riya Dave2 July 2026 10:00 AM ISTResearchers have found in a new study that a qualitative study of patient experiences found that GLP-1 receptor agonists (GLP-1 RAs) act as a...
Experimental Pill Shows Promise for Type 2 Diabetes and Obesity: Study Dr Kartikeya Kohli8 Jun 2026 8:15 PM ISTResearchers have found in a new study that a new experimental oral medication for type 2 diabetes and obesity may offer a novel treatment approach by...
GLP-1 Agonists Linked to Reduced Pain Medication Use and Fewer Pancreatic Procedures in Chronic Pancreatitis: Study Medha Baranwal8 Jun 2026 8:00 PM ISTUK: A real-world study published in Gastro Hep Advances found that GLP-1 receptor agonists were associated with lower use of pain medications and...
GLP-1 Drugs Show Potential Benefits-and Risks in Eye Diseases, reports review Dr Riya Dave25 May 2026 8:15 PM ISTA review published in BMC Ophthalmology has found that GLP-1 receptor agonists may help protect against ocular hypertension, glaucoma, late-stage...
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk Dr Pooja N.22 May 2026 6:00 AM ISTNew Hope for Women Facing Endometrial Cancer RisksEndometrial cancer is now the most common gynecologic cancer in developed countries, with cases on...
Choosing Safer Diabetes Medications for Older Adults, suggests study Dr. Kamal Kant Kohli1 May 2026 9:00 PM ISTOlder adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often...
GLP-1 Therapy Linked to Lower Atrial Fibrillation and Mortality Risk-Independent of Weight Loss: Study Dr. Kamal Kant Kohli25 April 2026 10:00 AM ISTUse of GLP-1 medications is associated with a reduced risk of atrial fibrillation and death, and this protective effect appears independent of weight...
GLP-1 Receptor Agonists Linked to Mild Erectile Dysfunction Risk: The Lancet Dr Kartikeya Kohli23 April 2026 9:00 AM ISTUSA: Prior evidence on the association between GLP-1 receptor agonists and erectile dysfunction (ED) in men with type 2 diabetes has been...
No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs Susmita Roy18 April 2026 8:51 PM ISTNew Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against...
GLP-1 Therapy Interruption Increases Cardiovascular Risk in Type 2 Diabetes: Study Dr Riya Dave10 April 2026 10:45 AM ISTA target trial emulation study has found that a 6-month break in GLP-1 drug therapy in patients with type 2 diabetes was associated with a higher risk...
GLP-1 Receptor Agonists linked to modest reduction of risk of Femur Fracture: Study Jacinthlyn Sylvia9 April 2026 9:15 AM ISTA new study published in the journal of Bone that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modest reduction...
GLP-1 Receptor Agonists Reduce Cardiovascular Risk Among Atopic Dermatitis Patients, Suggests Study Medha Baranwal5 April 2026 8:15 PM ISTUSA: Researchers have found in a new study that patients with atopic dermatitis who used GLP-1 receptor agonists showed a lower long-term risk of...
